Skip to main content

Research Repository

Advanced Search

Preclinical pharmacology of robenacoxib: a novel selective inhibitor of cyclooxygenase-2

King, J N; Dawson, J; Esser, R E; Fujimoto, R; Kimble, E F; Maniara, W; Marshall, P J; O'Byrne, L; Quadros, E; Toutain, P L; Lees, P

Authors

J N King

J Dawson

R E Esser

R Fujimoto

E F Kimble

W Maniara

P J Marshall

L O'Byrne

E Quadros

P L Toutain

P Lees



Citation

King, J. N., Dawson, J., Esser, R. E., Fujimoto, R., Kimble, E. F., Maniara, W., …Lees, P. Preclinical pharmacology of robenacoxib: a novel selective inhibitor of cyclooxygenase-2. Journal of Veterinary Pharmacology and Therapeutics, 32(1), 1-17. https://doi.org/10.1111/j.1365-2885.2008.00962.x

Journal Article Type Article
Deposit Date Nov 11, 2014
Journal JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS
Print ISSN 0140-7783
Publisher American Academy of Veterinary Pharmacology and Therapeutics
Volume 32
Issue 1
Pages 1-17
DOI https://doi.org/10.1111/j.1365-2885.2008.00962.x
Public URL https://rvc-repository.worktribe.com/output/1426181
Additional Information Corporate Creators : Ecole Nationale Veterinaire De Toulouse, Novartis Animal Health, Novartis Institute